CAS 1935694-88-4

Spartalizumab

CAS: 1935694-88-4

"Spartalizumab (PDR001), a humanized IgG4 monoclonal antibody, targets PD-1 to inhibit PD-L1/L2 interactions, useful in ATC research."

Reinheit: SDS-PAGE:95.2%;SEC-HPLC:96.3%

Farbe und Form: Liquid

Molekulargewicht: 145.74 kDa

Ref: TM-T77075

Spartalizumab

CAS: 1935694-88-4

Monoclonal antibody targeting PD-1 (CD279), being researched for melanoma

Ref: 3D-CLA1490